Coral Genomics Funding & Investors
Coral develops new clinical tests to help providers streamline prior authorization and select the effective medication for a particular patient focusing on autoimmune conditions such as Inflammatory Bowel Disease and Rheumatoid Arthritis. It has also identified a unique population of non-responder patients and is working with drug developers to address this unmet medical need.
https://www.coralgenomics.com/Total Amount Raised: $5,700,000
Coral Genomics Funding Rounds
Grant
$1,700,000
Grant Investors
National Institutes of Health (NIH)Grant
$2,000,000
Grant Investors
NHGRISeed
$2,000,000
Seed Investors
Soma Capital8VCY Combinator
Funding info provided by Diffbot.